Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Benin has been on the rise in recent years, driven by a combination of factors such as increasing awareness of skin health and growing disposable income levels.
Customer preferences: Customers in Benin are increasingly looking for dermatological drugs that are effective and affordable. They also prefer products that are easily accessible and available in local pharmacies. Due to the hot and humid climate in Benin, many customers are looking for products that can help them manage skin conditions such as acne, eczema, and fungal infections.
Trends in the market: One of the major trends in the dermatological drugs market in Benin is the increasing availability of generic drugs. This has made dermatological drugs more affordable for customers, as generic drugs are often priced lower than branded drugs. Another trend is the growing demand for natural and organic products, as customers become more health-conscious and concerned about the potential side effects of synthetic drugs. This trend is reflected in the increasing availability of natural and organic dermatological products in local pharmacies.
Local special circumstances: Benin is a low-income country with a predominantly rural population. This has implications for the dermatological drugs market, as many customers may not have access to specialized dermatologists or clinics. As a result, customers often rely on over-the-counter products available in local pharmacies. In addition, the hot and humid climate in Benin can exacerbate skin conditions, leading to a higher demand for dermatological drugs.
Underlying macroeconomic factors: The dermatological drugs market in Benin is influenced by a range of macroeconomic factors, including the country's GDP growth rate, inflation rate, and exchange rate. As the economy grows and disposable income levels rise, customers are more likely to spend money on skin care products, including dermatological drugs. In addition, fluctuations in the exchange rate can impact the availability and affordability of imported dermatological drugs. Finally, the government's healthcare policies and regulations can also impact the market, including regulations around drug pricing and availability.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
